Drug Prices

Injectable drugs

Pharmalot

Trump plan to give private Medicare leverage over drug costs would boost PBMs and biosimilars

By Ed Silverman

Rep. Greg Walden

Pharmalot

Republican lawmakers want FTC to probe PBM mergers over drug pricing concerns

By Ed Silverman

advertisement

Pharmalot

A federal appeals court just slammed the door on Allergan’s deal with the Mohawk tribe

By Ed Silverman

advertisement

Pharmalot

Pharmalot

U.K. health officials make a counteroffer to Vertex for its pricey cystic fibrosis drugs

By Ed Silverman

Pharmalot

Pharmalot

Under pressure from Trump, Pfizer agrees to roll back price hikes

By Ed Silverman

Prison

Pharmalot

Can a federal drug discount program unlock savings for state prisons?

By Ed Silverman

Pharmalot

Pharmalot

Aetna pressures whistleblower who alleged CVS Caremark ripped off Medicare

By Ed Silverman

advertisement

Pharmalot

Pharmalittle: Amgen migraine drug costs less than expected; J&J halts development on Alzheimer’s drug

By Ed Silverman

advertisement

Prescription Medication

Pharmalot

AbbVie and J&J reverse course on a price hike in face of criticism

By Ed Silverman

Drug Prices

Pharmalot

Martin Shkreli was hardly an outlier when it came to jacking up prices on older drugs

By Ed Silverman

Drug Prices

Pharmalot

U.S. spending on prescription drugs rose less than 1 percent last year

By Ed Silverman

Pharmalot

Pharmalittle: Amgen migraine drug show promise; DEA moves to tighten opioid rules

By Ed Silverman

Pharmalot

Pharmalittle: Sanofi warns Canada over industry treatment; Pfizer got a big boost from the new tax law

By Ed Silverman

Gilead Sciences

Pharmalot

Will this experimental hepatitis C treatment break Gilead’s grip on middle-income countries?

By Ed Silverman

NIH headquarters

Pharmalot

NIH is urged to probe Aegerion patents for failing to disclose federal funding

By Ed Silverman

Pharmalot

Pharmalittle: Pfizer paid its CEO how much? Glaxo says Brexit will not be cheap

By Ed Silverman

Clogged Artery

Biotech

Wall Street reacts to Regeneron, Sanofi cholesterol drug study results

By Adam Feuerstein and Damian Garde

Martin Shkreli & Benjamin Brafman

Adam's Take

Martin Shkreli has been sentenced. The drug industry is trying to get away scot-free

By Adam Feuerstein

Pricey Drugs

Pharmalot

UnitedHealthcare will pass some rebates to consumers, but will this really lower drug prices?

By Ed Silverman

Anthony Anex/Keystone via AP

Pharmalot

Advocates protest Novartis ‘bullying tactics’ over access to medicines in poor countries

By Ed Silverman

Len Schleifer

Pharmalot

Despite ‘responsible’ price, Regeneron drug kept out of many patients’ hands by payers

By Ed Silverman

Adam's Take

Acadia Pharma raised the price of its only drug twice but quarterly sales still disappoint

By Adam Feuerstein

Pharmalot

A reversal of fortunes: Judge voids order Gilead must pay $2.5B to Merck over a patent dispute

By Ed Silverman

John McCain- Glioblastoma

Pharmalot

McCain and Baldwin to Trump: Hold pharma’s feet to the fire on drug prices

By Ed Silverman

Pharmalot

Pharmalittle: Supermarkets sue over generic price fixing; Daiichi can collect that $550 million award

By Ed Silverman

Drug Discount Program

Pharmalot

Drug makers are offering bigger discounts than ever before

By Ed Silverman

Pharmalot

Pharmalittle: J&J slams U.K. cost-effectiveness watchdog; U.S. fights U.N. access plan

By Ed Silverman

Pharmalot

Pharmalittle: Judge wants to settle opioid suits quickly; Glaxo eyes Pfizer consumer biz

By Ed Silverman

Three vials

Business

Spark prices its gene therapy as most expensive U.S. medicine — but with plans to ease cost concerns

By Adam Feuerstein and Damian Garde